Effects of pranidipine, a new calcium antagonist, on circulation in the choroid, retina and optic nerve head

Current Eye Research

Volumn 19, Issue 3, 1999, Pages 241-247

  Tamaki, Yasuhiro ^a   Araie, Makoto ^b   Tomita, Ken ^c   Urashima, Hiroki ^d  

^a Tokyo Metropolitan Institute of Gerontology   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO KOSEI NENKIN HOSPITAL   (Japan)

^d OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Fundus circulation; Laser speckle method; Pranidipine; Rabbit

Indexed keywords

CALCIUM ANTAGONIST; PRANIDIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CHOROID; CIRCULATION; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RABBIT; RETINA;

ANIMALS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CHOROID; DIHYDROPYRIDINES; LASER-DOPPLER FLOWMETRY; OPTIC DISK; RABBITS; REGIONAL BLOOD FLOW; RETINAL VESSELS; TIME FACTORS; VASODILATION;

EID: 0032750528     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.19.3.241.5318     Document Type: Article

References (32)

1. Cohn JN. Calcium, vascular smooth muscle, and calcium entry blockers in hypertension. Ann Int Med. 1983;98 (Part 2):806-809.
2. Hof RP. Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem. Br J Pharmacol. 1983;78:375-394.
3. Ohtsuka M, Yokota M, Kodama I, Yamada K, Shibata S. New generation dihydropyridine calcium entry blockers: in search of greater selectivity for one tissue subtype. Gen Pharmacol. 1989;20:539-556.
4. Takenaka T, Handa J. Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys and human patients. Int J Clin Pharmacol Ther Toxicol. 1979;17:1-11.
5. Harino S, Riva CE, Petrig BL. Intravenous nicardipine in cats increases optic nerve head, but not retinal blood flow. Invest Ophthalmol Vis Sci. 1992;33:2885-2890.
6. Tamaki Y, Araie M, Tomita K, Tomidokoro T. Time change of nicardipine effect on choroidal circulation in rabbit eyes. Curr Eye Res. 1996;15:543-548.
7. Fechtner R, Weinreb RN. Mechanism of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol. 1994;39:23-42.
8. Flammer J. The vascular concept of glaucoma. Surv Ophthalmol. 1994;38(Suppl): S3-S6.
9. Kitazawa Y, Shirai H, Go FJ. The effect of Ca2+-antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 1989;227:408-412.
10. Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol. 1993;115:608-613.
11. Bose S, Piltz JR, Breton ME. Nimodipine, a centrally active calcium antagonist, exerts a beneficial effect on contrast sensitivity in patients with normal-tension glaucoma. Ophthalmology. 1995;102:1236-1241.
12. Sawada A, Kitazawa Y, Yamamoto T, Okabe I, Ichien K. Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma. Ophthalmology. 1996;103:283-288.
13. Koseki N, Araie M, Yamagami J, Shirato S, Yamamoto S. Effects of oral brovincamine on visual field damage in normal tension glaucoma with low-normal pressure. J Glaucoma, (in press)
14. Nakayama N, Ikezono K, Mori T, Yamashita S, Nakayama S, Tanaka Y, Hosokawa T, Minamai Y, Masutani K, Yamamura Y, Yabuuchi Y. Antihypertensive activity of OPC-13340, a new potent and long-acting dihydropyridine calcium antagonist, in rats. J Cardiovasc Pharmacol. 1990;15:836-844.
15. Mori T, Nakayama N, Ohura M, Ikezono K, Kinoshita S, Kamata M, Hosokawa T, Yamashita S, Yabuuchi Y. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs. Arch Int Pharmaco Ther. 1993;321:41-56.
16. Nakayama N, Ikezono K, Fujio N, Sasabe H, Kitaura K, Tamada S, Shirafuji T, Yabuuchi Y. OPC-13340, a new potent and long-acting dihydropyridine calcium antagonist. Cardiovasc Drug Rev. 1991;9:147-157.
17. Miyakoda G, Nakayama N, Matsui K, Yabuuchi Y. Mechanisms of potent and long-lasting antihypertensive action of the new calcium channel blocker pranidipine. Evidence for strong affinity to the calcium channels or membranes. Arzneim-Forsch/Drug Res. 1995;45(I),4,471-47.
18. Nakayama N, Ikezono K, Ohura M, Yabuuchi Y. Effects of the new long-acting dihydropyridine calcium antagonist pranidipine on the endothelium-dependent relaxation in isolated rat aorta in vitro. Arzneim-Forsch/Drug Res. 1993;43(II),12,1266-1270.
19. Tamaki Y, Araie M, Kawamoto E, Eguchi S, Fujii H. Noncontact, two-dimensional measurement of retinal microcirculation using laser speckle phenomenon. Invest Ophthalmol Vis Sci. 1994;35:3825-3834.
20. Tamaki Y, Araie M, Kawamoto E, Eguchi S, Fujii H. Non-contact, two-dimensional measurement of tissue circulation in choroid and optic nerve head using laser speckle phenomenon. Exp Eye Res. 1995;60:373-374.
21. Tamaki Y, Araie M, Tomita K, Nagahara M, Tomidokoro A, Fujii H. Real-time measurement of human optic nerve head and choroid circulation, using laser speckle phenomenon. Jpn J Ophthalmol. 1997;41:49-54.
22. Fercher AF, Briers JD. Flow visualization by means of single exposure speckle photography. Opt Commun. 1981;37:326-330.
23. Kozuma C, Macklin W, Cummins LM, Mauer R. Anatomy, physiology, and biochemistry of the rabbit. In: Weisbroth SH, Flatt RE, Kraus AL, eds. The Biology of the Laboratory Rabbit New York: Academic Press; 1974:50-72.
24. Sugiyama T, Utsumi T, Azuma I, Fujii H. Measurement of optic nerve head circulation: Comparison of laser speckle and hydrogen clearance methods. Jpn J Ophthalmol. 1996;40:339-343.
25. Alm A. Ocular circulation. In: Hart WM Jr, ed. Adler's Physiology of the Eye (9th ed). St. Louis, MO: CV Mosby; 1992:198-227.
26. Kiel JW, van Heuven WAJ. Ocular perfusion pressure and choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci. 1995;36:579-585.
27. Altura BM, Altura BT, Carella A, Turlapaty PDMV, Weinberg J. Vascular smooth muscle and general anesthetics. Federation Proceedings. 1980;39:1584-1591.
28. Maggi CA, Meli A. Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 2: Cardiovascular system. Experimentia. 1986;42:292-297.
29. Tamaki Y, Araie M, Tomita K, Tomidokoro A. Time-course of changes in nicardipine effects on microcirculation in retina and optic nerve head in living rabbit eyes. Jpn J Ophthalmol. 1996;40:202-211.
30. Cunha-Vaz JG, Shakib M, Ashton N. Studies on the permeability of the blood-retinal barrier. 1. On the existence, development, and site of a blood-retinal barrier. Br J Ophthalmol. 1966;50:441-453.
31. Olsson Y, Kristensson K . Permeability of blood vessels and connective tissue sheaths in retina and optic nerve. Acta Neuropath. 1973;26:147-156.
32. Sugiyama K, Bacon DR, Cioffi GA et al. The effects of phenylephrine on the ciliary body and optic nerve head microvasculature in rabbits. J Glaucoma. 1992;1:156-64.